Mark Zuckerberg and wife Dr. Priscilla Chan recently announced a $3 billion initiative geared towards curing most of the world’s diseases called the Biohub. Through the Chan Zuckerberg Initiative, the couple managed to draw support from other billionaires and ordinary people alike in terms of funding and cooperation. Recently, the Facebook founder released a post detailing how a meeting with top scientists gave him hope that most, if not all of the world’s diseases will be gone by 2115.
The scientists in question are at the top of their fields with regards to dealing with illnesses and they come from multiple origins, including Stanford University and UC Berkeley. Heading the team is Dr. Cori Bargmann, who is a Rockefeller neuroscientist, Futurism reports.
Even with excellent brains behind the operation, the goal of eradicating even just a majority of the known diseases plaguing the world is a monumental undertaking. Much of the challenges has to do with research, which is a costly and time-consuming affair. The Biohub will take on a lot of the weight of the problems that usually prevent scientists from making swift progress, but even then, many would consider the 100-year timeline to be overly ambitious.
Zuckerberg and the team of scientists don’t seem to think so, however, and they point to the advancements that humanity has achieved in the last few decades in extending human lifespan. Global Futurist also notes how the initiative has already addressed one of the hurdles of getting to the point that they are aiming for; coordination.
There’s also the matter of the most recent innovations in medical and bioresearch to consider, which gives the lofty goals of a disease-free world a boost. There’s the new gene-editing tool called CRISPR, which is basically a starter kit for playing God. Then there’s the project called Cell Atlas, which aims to map all of the human body’s cells to address diseases that begin at the cellular level.


CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally
France Keeps Top Health Alert as Officials Brace for Another Heatwave 



